文献速递围术期管理与 ERAS急腹症与外科感染

术后常规麻醉访视对30天发病率与死亡率的影响:TRACE多中心阶梯楔形集群随机干预研究

Routine Postsurgical Anesthesia Visit to Improve 30-day Morbidity and Mortality: A Multicenter, Stepped-wedge Cluster Randomized Interventional Study (The TRACE Study).
PubMed 文献 · Ann Surg · 2021-05-24

该研究在荷兰9家医院纳入5473例择期非心脏手术患者,评估在常规MEWS基础上增加术后第1天和第3天标准化麻醉访视对30天死亡率的影响。结果显示两组30天死亡率无显著差异(0.56% vs 0.44%,OR 0.74,95%CI 0.34-1.62),除肾脏并发症对照组更高外,其他并发症及住院时间无差异。

要点

  • 术后麻醉访视联合MEWS未降低30天死亡率。
  • 肾脏并发症对照组高于干预组(1.7% vs 1.0%,P=0.014)。
  • 麻醉访视建议的依从性约为67%-69%,可能影响效果。

核心结论

  • 在MEWS基础上增加术后第1天和第3天标准化麻醉访视未降低30天死亡率。
  • 术后麻醉访视对死亡率的影响是否因高依从性或高危人群而不同尚待确定。

研究设计与样本

  • 前瞻性、多中心、阶梯楔形集群随机干预研究,在荷兰9家学术和非学术医院开展。
  • 共5473例择期非心脏手术患者签署知情同意,5190例纳入统计分析(对照组2490例,干预组2700例)。
  • 干预措施为在常规MEWS基础上增加术后第1天和第3天标准化麻醉访视。
  • 主要结局为30天死亡率,次要结局包括术后并发症发生率、住院时间和ICU入住。

主要发现

  • 30天死亡率对照组0.56%(n=14),干预组0.44%(n=12),OR 0.74(95%CI 0.34-1.62)。
  • 除肾脏并发症外,两组术后并发症发生率无差异;肾脏并发症对照组1.7%(n=41)高于干预组1.0%(n=27),P=0.014。
  • 两组中位住院时间无显著差异。
  • 术后麻醉访视中,第1天16%(n=437)和第3天11%(n=293)的患者获得建议,其中分别67%(n=293)和69%(n=202)得到随访。

临床怎么用

  • 不应仅依赖术后标准化麻醉访视来降低择期非心脏手术患者的30天死亡率。
  • MEWS联合术后麻醉访视可作为术后监测的补充,但需关注建议的依从性。

局限性

  • 干预建议的随访依从性约为67%-69%,可能削弱干预效果。
  • 研究纳入的是中高危择期非心脏手术患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the impact of a standardized postoperative anesthesia visit on 30-day mortality in medium to high-risk elective surgical patients. BACKGROUND: Postoperative complications are the leading cause of perioperative morbidity and mortality. Although modified early warning scores (MEWS) were instituted to monitor vital functions and improve postoperative outcome, we hypothesized that complementary anesthesia expertise is needed to adequately identify early deterioration. METHODS: In a prospective, multicenter, stepped-wedge cluster randomized interventional study in 9 academic and nonacademic hospitals in the Netherlands, we studied the impact of adding standardized postoperative anesthesia visits on day 1 and 3 to routine use of MEWS in 5473 patients undergoing elective noncardiac surgery. Primary outcome was 30-day mortality. Secondary outcomes included: incidence of postoperative complications, length of hospital stay, and intensive care unit admission. RESULTS: Patients were enrolled between October 2016 and August 2018. Informed consent was obtained from 5473 patients of which 5190 were eligible for statistical analyses, 2490 in the control and 2700 in the intervention group. Thirty-day mortality was 0.56% (n = 14) in the control and 0.44% (n = 12) in the intervention group (odds ratio 0.74, 95% Confidence interval 0.34-1.62). Incidence of postoperative complications did not differ between groups except for renal complications which was higher in the control group (1.7% (n = 41) vs 1.0% (n = 27), P = 0.014). Median length of hospital stay did not differ significantly between groups. During the postanesthesia visits, for 16% (n = 437) and 11% (n = 293) of patients recommendations were given on day 1 and 3, respectively, of which 67% (n = 293) and 69% (n = 202) were followed up. CONCLUSIONS: The combination of MEWS and a postoperative anesthesia visit did not reduce 30-day mortality. Whether a postoperative anesthesia visit with strong adherence to the recommendations provided and in a high-risk population might have a stronger impact on postoperative mortality remains to be determined. TRIAL REGISTRATION: Netherlands Trial Registration, NTR5506/ NL5249, https://www.trialregister.nl/trial/5249.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Routine Postsurgical Anesthesia Visit to Improve 30-day Morbidity and Mortality: A Multicenter, Stepped-wedge Cluster Randomized Interventional Study (The TRACE Study). Ann Surg. 2021. PMID: 34029230. doi:10.1097/SLA.0000000000004954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。